IDEXX LABORATORIES INC /DE Increase (Decrease) in Deferred Revenue
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Deferred Revenue of -$3.25 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-01
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$1.93M, a 234.71% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$1.33M, a 382.94% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $1.27M, a 67.17% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $381.00K, a 46.34% decline year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for fiscal 2017 was $3.55M, a 53.71% decline from fiscal 2016.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for fiscal 2016 was $7.67M.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for fiscal 2015 was -$319.00K, a 102.25% decline from fiscal 2014.
- IDEXX LABORATORIES INC /DE increase (decrease) in deferred revenue for fiscal 2014 was $14.20M, a 120.35% increase from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$3.25M 10-Q · filed 2018-08-01 | -$1.98M derived: sum of 3 quarters · filed 2018-08-01 | -$1.60M derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | -$1.33M 10-Q · filed 2018-05-04 | -$55.00K derived: sum of 2 quarters · filed 2018-05-04 | $326.00K derived: sum of 3 quarters · filed 2018-05-04 | $1.75M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.65M derived: sum of 2 quarters · filed 2018-02-16 | $3.08M derived: sum of 3 quarters · filed 2018-08-01 | $3.55M 10-K · filed 2018-02-16 |
| 2017-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.81M derived: sum of 2 quarters · filed 2018-08-01 | $2.28M 10-Q · filed 2017-10-31 | $6.15M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.90M 10-Q · filed 2018-08-01 | $5.77M derived: sum of 3 quarters · filed 2018-08-01 | $6.48M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $469.00K 10-Q · filed 2018-05-04 | $4.34M derived: sum of 2 quarters · filed 2018-05-04 | $5.05M derived: sum of 3 quarters · filed 2018-05-04 | $7.50M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $4.58M derived: sum of 2 quarters · filed 2018-02-16 | $7.04M derived: sum of 3 quarters · filed 2018-02-16 | $7.67M 10-K · filed 2018-02-16 |
| 2016-09-30 | $710.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $3.16M derived: sum of 2 quarters · filed 2017-10-31 | $3.80M 10-Q · filed 2017-10-31 | $6.17M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $3.09M 10-Q · filed 2017-08-01 | $5.46M derived: sum of 3 quarters · filed 2018-02-16 | $3.48M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $637.00K 10-Q · filed 2017-04-28 | $3.01M derived: sum of 2 quarters · filed 2018-02-16 | $1.02M derived: sum of 3 quarters · filed 2018-02-16 | -$835.00K derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $387.00K derived: sum of 2 quarters · filed 2018-02-16 | -$1.47M derived: sum of 3 quarters · filed 2018-02-16 | -$319.00K 10-K · filed 2018-02-16 |
| 2015-09-30 | -$1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$3.84M derived: sum of 2 quarters · filed 2016-11-01 | -$2.69M 10-Q · filed 2016-11-01 | -$59.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$706.00K 10-Q · filed 2016-08-02 | $1.92M derived: sum of 3 quarters · filed 2017-02-17 | $5.35M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $1.15M 10-Q · filed 2016-04-29 | $3.78M derived: sum of 2 quarters · filed 2017-02-17 | $7.21M derived: sum of 3 quarters · filed 2017-02-17 | $12.12M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $6.06M derived: sum of 2 quarters · filed 2017-02-17 | $10.97M derived: sum of 3 quarters · filed 2017-02-17 | $14.20M 10-K · filed 2017-02-17 |
| 2014-09-30 | $3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $8.34M derived: sum of 2 quarters · filed 2015-10-28 | $11.57M 10-Q · filed 2015-10-28 | $13.96M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $8.14M 10-Q · filed 2015-07-30 | $10.53M derived: sum of 3 quarters · filed 2016-02-17 | $12.22M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $3.23M 10-Q · filed 2015-04-28 | $5.62M derived: sum of 2 quarters · filed 2016-02-17 | $7.30M derived: sum of 3 quarters · filed 2016-02-17 | $8.80M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $4.08M derived: sum of 2 quarters · filed 2016-02-17 | $5.57M derived: sum of 3 quarters · filed 2016-02-17 | $6.44M 10-K · filed 2016-02-17 |
| 2013-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $3.18M derived: sum of 2 quarters · filed 2014-10-24 | $4.05M 10-Q · filed 2014-10-24 | $5.79M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $2.36M 10-Q · filed 2014-07-25 | $4.10M derived: sum of 3 quarters · filed 2015-02-17 | $5.52M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $869.00K 10-Q · filed 2014-04-25 | $2.61M derived: sum of 2 quarters · filed 2015-02-17 | $4.02M derived: sum of 3 quarters · filed 2015-02-17 | $6.06M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $3.15M derived: sum of 2 quarters · filed 2015-02-17 | $5.19M derived: sum of 3 quarters · filed 2015-02-17 | $6.89M 10-K · filed 2015-02-17 |
| 2012-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-22 | $3.45M derived: sum of 2 quarters · filed 2013-10-22 | $5.15M 10-Q · filed 2013-10-22 | $9.47M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-23 | $3.74M 10-Q · filed 2013-07-23 | $8.06M derived: sum of 3 quarters · filed 2014-02-18 | $10.71M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $1.70M 10-Q · filed 2013-04-23 | $6.02M derived: sum of 2 quarters · filed 2014-02-18 | $8.67M derived: sum of 3 quarters · filed 2014-02-18 | $9.39M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $6.97M derived: sum of 2 quarters · filed 2014-02-18 | $7.70M derived: sum of 3 quarters · filed 2014-02-18 | $7.34M 10-K · filed 2014-02-18 |
| 2011-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-19 | $3.37M derived: sum of 2 quarters · filed 2012-10-19 | $3.02M 10-Q · filed 2012-10-19 | $2.82M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $724.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-20 | $369.00K 10-Q · filed 2012-07-20 | $169.00K derived: sum of 3 quarters · filed 2013-02-19 | $181.00K derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | -$355.00K 10-Q · filed 2012-04-20 | -$555.00K derived: sum of 2 quarters · filed 2013-02-19 | -$543.00K derived: sum of 3 quarters · filed 2013-02-19 | $1.49M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$188.00K derived: sum of 2 quarters · filed 2013-02-19 | $1.85M derived: sum of 3 quarters · filed 2013-02-19 | $2.37M 10-K · filed 2013-02-19 |
| 2010-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-21 | $2.05M derived: sum of 2 quarters · filed 2011-10-21 | $2.57M 10-Q · filed 2011-10-21 | $4.19M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-22 | $2.56M 10-Q · filed 2011-07-22 | $4.18M derived: sum of 3 quarters · filed 2012-02-17 | $4.17M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $524.00K 10-Q · filed 2011-04-21 | $2.15M derived: sum of 2 quarters · filed 2012-02-17 | $2.13M derived: sum of 3 quarters · filed 2012-02-17 | |
| 2009-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $1.61M derived: sum of 2 quarters · filed 2012-02-17 | $925.00K 10-K · filed 2012-02-17 | |
| 2009-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-22 | -$698.00K 10-Q · filed 2010-10-22 | ||
| 2009-06-30 | -$682.00K 10-Q · filed 2010-07-23 | |||
| 2008-12-31 | -$805.00K 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |